Yi Larson

2021 - LianBio

In 2021, Yi Larson earned a total compensation of $7.8M as Chief Financial Officer at LianBio.

Compensation breakdown

Non-Equity Incentive Plan$214,443
Option Awards$7,027,427
Salary$333,333
Stock Awards$218,113
Total$7,793,316

Larson received $7M in option awards, accounting for 90% of the total pay in 2021.

Larson also received $214.4K in non-equity incentive plan, $333.3K in salary and $218.1K in stock awards.

Rankings

In 2021, Yi Larson's compensation ranked 1,498th out of 12,406 executives tracked by ExecPay. In other words, Larson earned more than 87.9% of executives.

ClassificationRankingPercentile
All
1,498
out of 12,406
88th
Division
Manufacturing
542
out of 5,492
90th
Major group
Chemicals And Allied Products
204
out of 2,368
91st
Industry group
Drugs
169
out of 2,089
92nd
Industry
Pharmaceutical Preparations
115
out of 1,536
93rd
Source: SEC filing on April 27, 2022.

Larson's colleagues

We found three more compensation records of executives who worked with Yi Larson at LianBio in 2021.

2021

Yizhe Wang

LianBio

Chief Executive Officer

2021

Debra Yu

LianBio

President & Chief Strategy Officer

2021

Bing Li

LianBio

Chief Executive Officer

News

In-depth

You may also like